Orchid Pharma reports standalone net loss of Rs 68.52 crore in the September 2016 quarter
Sales decline 12.78% to Rs 183.59 crore
Net Loss of Orchid Pharma reported to Rs 68.52 crore in the quarter ended September 2016 as against net loss of Rs 68.94 crore during the previous quarter ended September 2015. Sales declined 12.78% to Rs 183.59 crore in the quarter ended September 2016 as against Rs 210.50 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales183.59210.50 -13 OPM %18.3120.61 -PBDT-37.63-32.36 -16 PBT-72.37-68.10 -6 NP-68.52-68.94 1Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 10 2016 | 9:42 AM IST